BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Prognosis
10 results:

  • 1. Hypoxia-activated neuropeptide Y/Y5 receptor/rhoa pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma.
    Lu C; Mahajan A; Hong SH; Galli S; Zhu S; Tilan JU; Abualsaud N; Adnani M; Chung S; Elmansy N; Rodgers J; Rodriguez O; Albanese C; Wang H; Regan M; Zgonc V; Blancato J; Krawczyk E; Gallicano GI; Girgis M; Cheema A; Iżycka-Świeszewska E; Cavalli LR; Pack SD; Kitlinska J
    Nat Commun; 2022 Apr; 13(1):2323. PubMed ID: 35484119
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma.
    Liao D; Zhong L; Yin J; Zeng C; Wang X; Huang X; Chen J; Zhang H; Zhang R; Guan XY; Shuai X; Sui J; Gao S; Deng W; Zeng YX; Shen JN; Chen J; Kang T
    Nat Cell Biol; 2020 Jul; 22(7):868-881. PubMed ID: 32483387
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Long noncoding RNA SchLAH suppresses metastasis of hepatocellular carcinoma through interacting with fused in sarcoma.
    Ge Z; Cheng Z; Yang X; Huo X; Wang N; Wang H; Wang C; Gu D; Zhao F; Yao M; Fan J; Qin W
    Cancer Sci; 2017 Apr; 108(4):653-662. PubMed ID: 28196303
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Expression of G Protein-coupled Receptor 56 Is an Unfavorable Prognostic Factor in Osteosarcoma Patients.
    Chen Z; Gao P; Li Z
    Tohoku J Exp Med; 2016 Jul; 239(3):203-11. PubMed ID: 27396430
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. RNAi-mediated silencing of AQP1 expression inhibited the proliferation, invasion and tumorigenesis of osteosarcoma cells.
    Wu Z; Li S; Liu J; Shi Y; Wang J; Chen D; Luo L; Qian Y; Huang X; Wang H
    Cancer Biol Ther; 2015; 16(9):1332-40. PubMed ID: 26176849
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The prognostic value of elevated vascular endothelial growth factor in patients with osteosarcoma: a meta-analysis and systemic review.
    Qu JT; Wang M; He HL; Tang Y; Ye XJ
    J Cancer Res Clin Oncol; 2012 May; 138(5):819-25. PubMed ID: 22274866
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Sixty percent 10-year survival of patients with chondrosarcoma after local recurrence.
    Lin PP; Alfawareh MD; Takeuchi A; Moon BS; Lewis VO
    Clin Orthop Relat Res; 2012 Mar; 470(3):670-6. PubMed ID: 21918803
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. rhoa GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation.
    Fromigué O; Haÿ E; Modrowski D; Bouvet S; Jacquel A; Auberger P; Marie PJ
    Cell Death Differ; 2006 Nov; 13(11):1845-56. PubMed ID: 16470222
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of drug-regulated genes in osteosarcoma cells.
    Fellenberg J; Dechant MJ; Ewerbeck V; Mau H
    Int J Cancer; 2003 Jul; 105(5):636-43. PubMed ID: 12740912
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. An immunohistochemical study comparing clear cell sarcoma of the kidney and Wilms' tumor.
    Looi LM; Cheah PL
    Pathology; 1993 Apr; 25(2):106-9. PubMed ID: 8396229
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.